These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23681918)

  • 1. Triplex-forming oligonucleotides targeting c-MYC potentiate the anti-tumor activity of gemcitabine in a mouse model of human cancer.
    Boulware SB; Christensen LA; Thames H; Coghlan L; Vasquez KM; Finch RA
    Mol Carcinog; 2014 Sep; 53(9):744-52. PubMed ID: 23681918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting oncogenes to improve breast cancer chemotherapy.
    Christensen LA; Finch RA; Booker AJ; Vasquez KM
    Cancer Res; 2006 Apr; 66(8):4089-94. PubMed ID: 16618728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.
    Ganguly K; Bhatia R; Rauth S; Kisling A; Atri P; Thompson C; Vengoji R; Ram Krishn S; Shinde D; Thomas V; Kaur S; Mallya K; Cox JL; Kumar S; Batra SK
    Gastroenterology; 2022 Jan; 162(1):253-268.e13. PubMed ID: 34534538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
    Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
    Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
    McGuffie EM; Pacheco D; Carbone GM; Catapano CV
    Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma.
    Tonkinson JL; Worzalla JF; Teng CH; Mendelsohn LG
    Cancer Res; 1999 Aug; 59(15):3671-6. PubMed ID: 10446980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
    Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
    Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between cisplatin and gemcitabine in vitro and in vivo.
    Peters GJ; Bergman AM; Ruiz van Haperen VW; Veerman G; Kuiper CM; Braakhuis BJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):72-9. PubMed ID: 7481849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D; Raina K; Kumar D; Wempe MF; Bagby SM; Pitts TM; Orlicky DJ; Agarwal C; Messersmith WA; Agarwal R
    Mol Carcinog; 2020 Oct; 59(10):1227-1240. PubMed ID: 32816368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors.
    Prudner BC; Rathore R; Robinson AM; Godec A; Chang SF; Hawkins WG; Hirbe AC; Van Tine BA
    Clin Cancer Res; 2019 Aug; 25(16):5122-5134. PubMed ID: 31113844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.
    Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT; Wang H; Wang QW; Pan MS; Li XP; Sun W; Fan YZ
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):221-232. PubMed ID: 32654071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.
    Chougule MB; Patel A; Sachdeva P; Jackson T; Singh M
    PLoS One; 2011; 6(11):e27394. PubMed ID: 22102891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
    McGuffie EM; Catapano CV
    Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.
    Seo HK; Ahn KO; Jung NR; Shin JS; Park WS; Lee KH; Lee SJ; Jeong KC
    Oncotarget; 2014 Jan; 5(2):326-37. PubMed ID: 24504118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.
    Gong JH; Zheng YB; Zhang MR; Wang YX; Yang SQ; Wang RH; Miao QF; Liu XJ; Zhen YS
    Cancer Biol Ther; 2020 Apr; 21(4):332-343. PubMed ID: 31906826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene.
    Cho JG; Kim MK; Oh EJ; Yoon EJ; Sohn J; Park MK; Park GH
    Mol Cells; 2002 Aug; 14(1):93-100. PubMed ID: 12243359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM
    Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
    Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K
    Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.